Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Hungary

Hungary Is Cancer Hotspot

May 2006 | Company Finance Alert

According to BMI, sales of anticancer agents in Hungary last year were an estimated US$231mn, representing the third largest therapeutic group behind cardiovascular drugs and metabolic/alimentary tract medicines. However, by 2009, oncology drugs sales are forecast to reach US$392mn, thereby becoming the second biggest therapeutic

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
Government Encourages Mobile Pharmacies

Companies / Hungary The Hungarian government is looking to introduce mobile pharmacies help support traditional outlets in under-served areas. The mobile pharmacy units will be positioned near outpatient medical facilities...
July 2007
Ruling Coalition Delays Hungarian Healthcare Reforms

Companies / Hungary Healthcare issues are expected to be addressed last at talks between Hungary's recently elected coalition of the Socialist Party (MSZP) and the liberal Free Democrats (SZDSZ), because the sector is not...
April 2006
Hungarian Government Suspends Talks With Industry

Companies / Hungary Due to the upcoming elections, the Hungarian government and pharmaceutical companies have suspended their discussions regarding drug subsidies and mandatory contributions by industry to the national...
April 2006
Hungary To List Contraceptives

Companies / Hungary Media reports claim Hungary's ailing state reimbursement system is to cover contraceptives manufactured by leading domestic firm Gedeon Richter. The company controls a 34% share of the oral contraceptives...
April 2006
Price Increases Enlarge Hungary's Drugs Budget Deficit

Companies / Hungary The prices of 42 non-reimbursed pharmaceuticals have been increased in Hungary, further enlarging the country's drugs budget deficit, which is expected to reach HUF80bn (US$361bn) this year. Separately,...
March 2006
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS